The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can ...

The National Institute for Health and Care Excellence (NICE) has recommended Gideon Richter’s Ryeqo (relugolix, estradiol and ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...

The drug, also called Relugolix, blocks signals from the brain that tell the ovaries to make oestrogen, a hormone that fuels ...

Ryeqo drug is hailed as a ‘potential step-change’ in how endometriosis is treated A new pill designed to transform the ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

But now the NHS England has approved a daily pill that could help manage pain and other symptoms for those living with the ...

Women’s health experts have issued a warning about the limitations of the first-of-its-kind endometriosis treatment pill, ...

Relugolix–estradiol–norethisterone, known as Ryeqo, is the first long-term daily treatment approved for endometriosis. It works by blocking hormones that contribute to the condition while also ...

Hoorah for some positive women's health news! A new endometriosis pill has been made available on the NHS in England, in what ...

The drug, called relugolix-estradiol-norethisterone (Ryeqo), was approved by the National Institute for Health and Care Excellence (NICE) and could help 1,000 women a year in England living with ...